- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03039920
The Effects of Electronic Cigarette Smoking on the Arterial Wall and Endothelial Glycocalyx Properties of Smokers
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Two smoker groups matched for age and sex will be assessed:
- a group of 30 current smokers with no diagnosed cardiovascular disease as the control group for chronic phase
- a group of 30 current smokers with no diagnosed cardiovascular disease who will be using the electronic cigarette with nicotine for 1 month
In the acute phase all 60 smokers will undergo a "sham" smoking for 7 minutes. Afterwards 30 out of 60 smokers will be randomized to smoke either a normal cigarette or an electronic cigarette with nicotine and after a 60 minute washout period these subjects will be crossed over to the alternate mode of smoking (electronic with nicotine or normal cigarette respectively).
The remaining 30 smokers will be randomized to smoke either a normal cigarette or an electronic cigarette without nicotine and after a 60 minute washout period these subjects will be crossed over to the alternate mode of smoking (electronic without nicotine or normal cigarette respectively.
After the completion of the acute phase all 60 smokers will start the use of an electronic cigarette for one month.
In the acute phase, measurements will be performed at baseline, after sham smoking and after smoking of the normal or electronic cigarette (with or without nicotine). The chronic phase measurements will be performed 1 month after use electronic cigarette with nicotine. Thirty current smokers of similar age and sex will serve as controls and will have measurements at baseline and 1 month after baseline assessment. The nicotine concentration of the electronic cigarette fluid used during both phases will be 12 mg/dL, while the participants will be allowed to use their cigarette of preference in the acute phase. In both phases we will assess a) the aortic pulse wave velocity (PWV) and augmentation index (AIx) by Arteriograph and Complior; b) the perfusion boundary region of the sublingual arterial microvessels using Sideview, Darkfield imaging (Microscan, Glycocheck); c) the exhaled carbon monoxide (CO) level (parts per million -ppm) as a smoking status marker; d) the vital signs; e) an electrocardiogram; and f) plasma levels of C- reactive protein (CRP), transforming growth factor-b (TGF-b), lipoprotein associated phospholipase A2 (LP- LPA2), tumor necrosis factor- α (TNF-α), interleukins 6 and 10 (IL-6 and -10), procollagen propeptide type III (PIIINP), matrix metalloproteinase 2 and 9 (MMP-2 and -9), and macrophage-colony stimulating factor (MCSF), malondialdehyde (MDA) and protein carbonyls (PC) and platelet function tests using the novel Platelet Function Analyzer PFA-100 and the traditional Light Transmission Aggregometry (LTA)
Type d'étude
Inscription (Anticipé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Attiki
-
Athens, Attiki, Grèce, 12462
- Recrutement
- ''Attikon'' University General Hospital
-
Contact:
- Ignatios Ikonomidis, MD
- Numéro de téléphone: 00302105831264
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Active conventional cigarette smoker
Exclusion Criteria:
- Health condition adversely affected by smoking, history or presence of cardiovascular disease
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Quadruple
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Comparateur actif: Electronic cigarette with or without nicotine
Electronic cigarette assisted cessation program
|
Smoking of electronic cigarette
|
Comparateur actif: Contrôle des fumeurs
Poursuite du tabagisme conventionnel
|
Smoking tobacco cigarette
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Acute electronic cigarette vaping effects on arterial stiffness.
Délai: 7 minutes
|
Acute electronic cigarette vaping effects on arterial stiffness as assessed by pulse wave velocity (PWV, m/sec).
PWV (m/sec) was measured by using tonometry by Complior (Alam Medical, Vincennes, France).
Two non-invasive pressure sensors were used to record the carotid and femoral waveforms and the distance between the two arterial sites was measured with a tape measure.
|
7 minutes
|
Acute electronic cigarette vaping effects on endothelial integrity.
Délai: 7 minutes
|
Acute electronic cigarette vaping effects on endothelial integrity as assessed by measuring endothelial glycocalyx thickness.
We measured the perfused boundary region (PBR) of the sublingual arterial microvessels (ranged from 5 to 25 μm) using Sidestream Darkfield Imaging (Microscan, Glycocheck, Microvascular Health Solutions Inc., Salt Lake City, UT, USA).
|
7 minutes
|
Chronic electronic cigarette vaping effects on arterial stiffness.
Délai: 1 month
|
Chronic electronic cigarette vaping effects on arterial stiffness, as assessed by pulse wave velocity (PWV, m/sec).
PWV (m/sec) was measured by using tonometry by Complior (Alam Medical, Vincennes, France).
Two non-invasive pressure sensors were used to record the carotid and femoral waveforms and the distance between the two arterial sites was measured with a tape measure.
|
1 month
|
Chronic electronic cigarette vaping effects on endothelial integrity.
Délai: 1 month
|
Chronic electronic cigarette vaping effects on endothelial integrity as assessed by measuring endothelial glycocalyx thickness.
We measured the perfused boundary region (PBR) of the sublingual arterial microvessels (ranged from 5 to 25 μm) using Sidestream Darkfield Imaging (Microscan, Glycocheck, Microvascular Health Solutions Inc., Salt Lake City, UT, USA).
|
1 month
|
Chronic electronic cigarette vaping effects on platelet aggregation.
Délai: 1 month
|
Chronic electronic cigarette vaping effects on platelet function as assessed by Light Transmission Aggregometry (LTA).
We measured both maximum (peak) and late platelet aggregation (%) (at 6 minutes) after addition of epinephrine (as stimulant) in platelet rich plasma.The 100% line was set using platelet poor plasma and a 0% baseline established with platelet rich plasma before addition of the agonist(epinephrine). Platelet aggregation is experssed as % of the 100% line
|
1 month
|
Chronic electronic cigarette vaping effects on high-shear stress-dependent platelet function.
Délai: 1 month
|
Chronic electronic cigarette vaping effects on high-shear stress-dependent platelet function as assesed by PFA-100.
The instrument estimates the ability of platelets activated in a high shear environment to occlude an aperture in a membrane coated with collagen and epinephrine (CEPI).The time taken for flow across the membrane to stop (closure time, CT, seconds) is recorded as measure of platelet function.
Platelet adhesion and aggregation following a vascular injury is simulated in vitro by PFA.
|
1 month
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Ignatios Ikonomidis, Dr, Attikon Hospital
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 698/11-3-15
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Electronic cigarette
-
China Medical University HospitalComplété
-
University of PittsburghRetiréAdhésion aux médicaments | Réaction indésirable au médicament | Non-observance des médicamentsÉtats-Unis
-
Cairo UniversityComplété
-
Cairo UniversityComplétéAnesthésie générale | Rééducation complète de la bouche | Relation de chevauchement caninEgypte
-
Jinan Military General HospitalInconnueVulve Intraépithélial Non néoplasiqueChine